about
Renal nitric oxide production in rat pregnancy: role of constitutive nitric oxide synthasesVascular oxidative stress in aging: a homeostatic failure due to dysregulation of NRF2-mediated antioxidant responseThe Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial.Surface markers of lymphocyte activation in pregnant asthmaticsIncreased circulating heat shock protein 70 levels in pregnant asthmatics.Circulating heat shock protein 70 (HSPA1A) in normal and pathological pregnancies.Patterns of erythropoiesis-stimulating agent use for chemotherapy-induced anemia in lung cancer: results of a retrospective Hungarian real-life clinical data analysis.Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulationCirculating survivin levels in healthy and asthmatic pregnancyRelationship of circulating soluble urokinase plasminogen activator receptor (suPAR) levels to disease control in asthma and asthmatic pregnancy.Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemiaExpiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer.Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy.Disruption of Nrf2 signaling impairs angiogenic capacity of endothelial cells: implications for microvascular aging.Asthma in pregnancy - from immunology to clinical management.Circulating factors induced by caloric restriction in the nonhuman primate Macaca mulatta activate angiogenic processes in endothelial cells.Aging-induced dysregulation of dicer1-dependent microRNA expression impairs angiogenic capacity of rat cerebromicrovascular endothelial cells.Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice.Longevity is associated with increased vascular resistance to high glucose-induced oxidative stress and inflammatory gene expression in Peromyscus leucopusResveratrol induces mitochondrial biogenesis in endothelial cells.Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats.Sarcoidosis lymphoma syndrome - the value of PET-CT in the diagnosis.Oxidative stress and accelerated vascular aging: implications for cigarette smoking.Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1.Unicentric mixed variant Castleman disease associated with intrabronchial plasmacytoma.Asthma in pregnancy--immunological changes and clinical management.Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.Effect of cigarette smoke and dexamethasone on Hsp72 system of alveolar epithelial cells.TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial.Seasonal changes of lower respiratory tract infections in lung transplant recipients during the first post-transplant year: The Hungarian experience.Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.Ceritinib in second and further lines of therapy in advanced ALK mutant adenocarcinoma.Lack of heritability of exhaled volatile compound pattern: an electronic nose twin study.[Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung cancer].Exercise increases exhaled breath condensate cysteinyl leukotriene concentration in asthmatic patients.Increased synthesis of vascular endothelial growth factor in allergic airway inflammation in histidine decarboxylase knockout (HDC(-/-)) mice.Adenosine triphosphate concentration of exhaled breath condensate in asthma.Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice.Specific expression of PAD4 and citrullinated proteins in lung cancer is not associated with anti-CCP antibody production.Exhaled nitric oxide in pregnant healthy and asthmatic women.
P50
Q23911045-758DF140-EF7F-48A5-91CC-2D88948F8E68Q29347088-669C3D04-E9A7-4F39-B9F9-0865F13BD659Q33430755-AA6E94C9-FE7B-4449-96B2-A3EB8300DDF4Q33577933-9F52AF54-A75C-4400-8D31-217A9287C9E6Q33838948-AD35DFB1-7871-4F3E-B4F1-4B38BCD66394Q33838958-45EFA281-FED4-45B6-B5E9-8B8BFD661A9DQ33867969-CF41615E-543B-4EE1-BBC8-0889A40022BAQ33962531-3F659F11-0909-47C6-8541-59272534069BQ34305838-D000F85C-BD0B-4302-93E8-C1F88E411595Q34658557-450924B5-BE1A-43C2-8F90-73AD90D45D6CQ34784446-E9EA004A-347D-413E-86B6-6779225B9F88Q34901092-976D3727-DC15-4AE7-8CA0-92E0548E7A13Q35149020-37DC3A15-C6DA-4C1E-9B00-072242F7ED71Q36112481-60818D3C-33F9-4A0C-9167-99332FF9D388Q36217576-F511241F-10DE-4FEA-957A-ED9D802B46C8Q36709361-7D44D1A1-FDD6-4FBE-BDD9-3750A550C818Q37015907-CA23AA40-6A4D-4BE7-84D8-36B928768C4DQ37038972-EF3E3AC9-EE6C-4022-8409-0F7B93C92354Q37162511-F6100C09-8881-478A-B9E8-8C3D76FFB86FQ37264427-FFBAE2A0-0090-44AE-A814-6668E4DEC88AQ37350177-C8D1CFE4-E26E-4B22-9FE5-03630411F4E0Q37363871-1E1430D5-E5D9-413C-A96F-999CFB6EDC51Q37373701-24DC99B9-67E0-4F64-9C10-828D56360E95Q37373849-63F30165-2F8C-45C0-B762-9B2A8B0E31A3Q37715422-5BBF11BE-290A-48F9-A88A-08D84FB396E3Q37818863-6DFAD489-5D92-4B1A-9C19-7DF254A9DA29Q39036930-0F606153-A1F1-4A6E-B73A-4DC815C17BADQ39614964-41989F5D-2E33-431B-AFC5-695843C25343Q40149008-F552B8E2-27ED-4AB9-809B-5271BC0CC53BQ40344121-E95E6994-F517-40A4-8B22-FC82327E2B92Q41692347-12839405-33BF-442D-BEAE-5D76188DAF4DQ41897412-102638C7-4B18-4678-BC6B-41CD10E77871Q42637523-5D09AB17-90E4-4C2E-BD6B-E986F5C10091Q42777199-40052CF0-866C-4B9B-AC01-AB1282415297Q42877280-FC296E49-9643-469C-8ACF-4960C5F8F2E1Q42935104-FE871E40-7EEB-47E4-8367-27BE14445247Q43103727-46E9DBD4-E22E-4711-A72E-325BAAE6BDD1Q43256331-CC8014CF-6D8A-4097-9556-302EF69B6E74Q43478030-58E09121-762F-4A51-951F-35BF23AA5509Q43845186-C968373E-D931-43F7-8EC9-BCDA5EDEE87F
P50
name
György Losonczy
@en
type
label
György Losonczy
@en
prefLabel
György Losonczy
@en